Ariceum doses first patient with satoreotide
The treatment targets extensive stage small cell lung cancer and aims to boost therapeutic impact
Read More
Tag: ariceum
Ariceum and UCB link up to take on immune-related diseases
The companies will use proprietary technology to enable the discovery of peptide-radioisotope conjugates
Read More
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
